Sintetica GmbH is a 100% subsidiary of Sintetica S.A. based in Mendrisio, Switzerland, and distributes pharmaceuticals and medical devices in Germany and Austria, primarily to hospitals, clinics and the pharmaceutical wholesale trade. The company acts as the marketing authorization holder and contractual partner, performing import and regulatory tasks for distribution partners entrusted with marketing in Northern and Eastern Europe. The product range primarily comprises medicines for regional anaesthesia, the treatment of hypotension, pain therapy and intrathecal therapy for chronic spasticity, and includes innovative formulations and dosage forms such as ready-to-use solutions. The production of the preparations is carried out by the parent company Sintetica S.A. in Switzerland at the group headquarters in Mendrisio/Ticino and at the production site in Couvet/Neuchâtel. The company is a small company under § 267 (1) HGB and is therefore not required to publish a profit-and-loss statement.
Gegenstand des Unternehmens ist die Entwicklung, der Vertrieb und die Herstellung von Arzneimitteln und anderen therapeutischen Substanzen. Die Gesellschaft kann den gewerblichen Handel mit Produkten, die von Dritten hergestellt werden, betreiben. Die Gesellschaft darf alle damit zusammenhängenden und den Unternehmensgegenstand fördernden Geschäfte tätigen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Münster Local Court, HRB 16618 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Andreas Menke | Geschäftsführer(in) | Münster |
Source: German Commercial Register (Handelsregister) Münster Local Court, HRB 16618 (as of 1 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 03.04.2017 | Company Name Registered | Sintetica GmbH |
| 03.04.2017 | Registered Seat | Münster |
| 03.04.2017 | Business Address Registered | Albersloher Weg 11, 48155 Münster |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 03.04.2017 | Share Capital Set | — | 100.000 € |
| Date | Contract | Value |
|---|---|---|
| 3.3.2026 | Supplier · PBMG eG | — |
Source: German Commercial Register (Handelsregister) Münster Local Court, HRB 16618 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | small company1 | €827,301 | €5,535,774 | — |
| 2024 | Rohergebnis€7.1M2 | €768,065 | €7,045,054 | — |
| 2023 | Rohergebnis€7.1M2 | €698,070 | €8,321,898 | — |
| 2022 | Rohergebnis€6.8M2 | €668,237 | €7,024,744 | — |
| 2021 | Rohergebnis€6.1M2 | €609,279 | €12,674,010 | — |
| 2020 | Rohergebnis€6.7M2 | €997,444 | €8,659,864 | — |
| 2019 | Rohergebnis€5.6M2 | €258,450 | €8,142,717 | — |
| 2018 | ≤ €12M1 | €200,231 | €7,383,417 | — |
| 2017 | small company1 | €40,562 | €5,394,917 | — |
| 2016 | — | -€528,063 | €4,399,823 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Münster Local Court, HRB 16618 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €2,705,297 | 98.9% |
| Depreciation | €27,019 | 1.0% |
| Interest & Similar | €2,600 | 0.1% |
